Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01925300

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

A Randomized, Open-label, Repeated-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Bisoprolol and Rosuvastatin in Healthy Adult Volunteers

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
HK inno.N Corporation · Industry
Sex
Male
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is designated to evaluate the pharmacokinetic interactions of bisoprolol and rosuvastatin in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGConcor 5mg(Bisoprolol hemifumarate 5mg) 2Tab
DRUGCrestor 20mg(Rosuvastatin calcium 20.80mg) 1Tab
DRUGConcor 5mg 2T and Crestor 20 mg 1Tab

Timeline

Start date
2013-07-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2013-08-19
Last updated
2016-12-29

Source: ClinicalTrials.gov record NCT01925300. Inclusion in this directory is not an endorsement.